fluorobenzenes has been researched along with Diabetic Glomerulosclerosis in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campese, VM | 1 |
| Anzalone, DA; Cain, VA; Cressman, MD; de Zeeuw, D; Heerspink, HJ; Molitoris, BA; Monyak, JT; Parving, HH; Remuzzi, G; Sowers, JR; Vidt, DG | 1 |
| Haynes, R; Wanner, C | 1 |
| Aso, Y; Inukai, T; Matsumoto, S; Suetsugu, M; Takebayashi, K | 1 |
| Allen, TJ; Calkin, AC; Cooper, ME; Forbes, JM; Giunti, S; Jandeleit-Dahm, KA; Thomas, MC | 1 |
| Abe, M; Ito, M; Maruyama, N; Okada, K; Soma, M; Yoshida, Y | 1 |
| Arai, H; Minami, M; Murayama, T; Tamura, Y; Yokode, M | 1 |
| Abe, M; Maruyama, N; Matsumoto, K; Matsumoto, S; Okada, K; Soma, M | 1 |
| Asahara, T; Ii, M; Kusano, KF; Losordo, DW; Nishimura, H; Qin, G; Wecker, A; Yoon, YS | 1 |
4 trial(s) available for fluorobenzenes and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trial.
Topics: Adult; Analysis of Variance; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Atorvastatin; Creatinine; Diabetes Complications; Diabetic Nephropathies; Dose-Response Relationship, Drug; Double-Blind Method; Europe; Fluorobenzenes; Heptanoic Acids; Humans; Kidney; Lipids; North America; Proteinuria; Pyrimidines; Pyrroles; Rosuvastatin Calcium; South America; Sulfonamides | 2015 |
Effects of rosuvastatin and colestimide on metabolic parameters and urinary monocyte chemoattractant protein-1 in type 2 diabetic patients with hyperlipidemia.
Topics: C-Reactive Protein; Chemokine CCL2; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dinoprost; Enzyme-Linked Immunosorbent Assay; Epichlorohydrin; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Imidazoles; Male; Middle Aged; Oxidative Stress; Peptide Fragments; Prospective Studies; Pyrimidines; Resins, Synthetic; Retinol-Binding Proteins; Rosuvastatin Calcium; Sulfonamides | 2009 |
Efficacy analysis of the lipid-lowering and renoprotective effects of rosuvastatin in patients with chronic kidney disease.
Topics: Aged; Blood Glucose; Blood Pressure; Cytoprotection; Diabetic Nephropathies; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome | 2011 |
Effects of lipid-lowering therapy with rosuvastatin on kidney function and oxidative stress in patients with diabetic nephropathy.
Topics: Aged; Albuminuria; Blood Pressure; C-Reactive Protein; Case-Control Studies; Cholesterol, HDL; Cystatin C; Diabetic Nephropathies; Female; Fluorobenzenes; Glycemic Index; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Diseases; Kidney Function Tests; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Oxidative Stress; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Triglycerides | 2011 |
5 other study(ies) available for fluorobenzenes and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Statins and the kidney: friend or foe?
Topics: Diabetes Complications; Diabetic Nephropathies; Fluorobenzenes; Heptanoic Acids; Humans; Kidney; Pyrimidines; Pyrroles; Sulfonamides | 2015 |
Chronic kidney disease: Statins in chronic kidney disease: time to move on?
Topics: Diabetes Complications; Diabetic Nephropathies; Fluorobenzenes; Heptanoic Acids; Humans; Kidney; Pyrimidines; Pyrroles; Sulfonamides | 2015 |
The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouse.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apolipoproteins E; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Drug Therapy, Combination; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Lipid Metabolism; Male; Mice; Mice, Knockout; Oxidative Stress; Pyrimidines; Rosuvastatin Calcium; Streptozocin; Sulfonamides; Tetrazoles | 2010 |
Differential effect of statins on diabetic nephropathy in db/db mice.
Topics: Adiposity; Albuminuria; Animals; Blood Pressure; Body Weight; Creatinine; Diabetic Nephropathies; Fluorobenzenes; Insulin Resistance; Male; Mice; Oxidative Stress; Pravastatin; Pyrimidines; Quinolines; Real-Time Polymerase Chain Reaction; Rosuvastatin Calcium; Sulfonamides | 2011 |
Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy.
Topics: Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Down-Regulation; Fluorobenzenes; Glucose; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mice; Mice, Mutant Strains; Nitric Oxide Synthase Type I; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyrimidines; Rosuvastatin Calcium; Schwann Cells; Sulfonamides; Treatment Outcome; Vasa Nervorum | 2005 |